Rapid Micro Biosystems Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.9301
- Today's High:
- $1.12
- Open Price:
- $0.98
- 52W Low:
- $0.83
- 52W High:
- $3.78
- Prev. Close:
- $0.95
- Volume:
- 111991
Company Statistics
- Market Cap.:
- $40.22 million
- Book Value:
- 3.299
- Revenue TTM:
- $19.15 million
- Operating Margin TTM:
- -334.58%
- Gross Profit TTM:
- $-8540000
- Profit Margin:
- 0%
- Return on Assets TTM:
- -21.24%
- Return on Equity TTM:
- -36.28%
Company Profile
Rapid Micro Biosystems Inc had its IPO on 2021-07-15 under the ticker symbol RPID.
The company operates in the Healthcare sector and Medical Devices industry. Rapid Micro Biosystems Inc has a staff strength of 177 employees.
Stock update
Shares of Rapid Micro Biosystems Inc opened at $0.98 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.93 - $1.12, and closed at $1.04.
This is a +9.47% increase from the previous day's closing price.
A total volume of 111,991 shares were traded at the close of the day’s session.
In the last one week, shares of Rapid Micro Biosystems Inc have increased by +8.33%.
Rapid Micro Biosystems Inc's Key Ratios
Rapid Micro Biosystems Inc has a market cap of $40.22 million, indicating a price to book ratio of 0.4293 and a price to sales ratio of 3.95.
In the last 12-months Rapid Micro Biosystems Inc’s revenue was $19.15 million with a gross profit of $-8540000 and an EBITDA of $-61248000. The EBITDA ratio measures Rapid Micro Biosystems Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Rapid Micro Biosystems Inc’s operating margin was -334.58% while its return on assets stood at -21.24% with a return of equity of -36.28%.
In Q2.3333333333333, Rapid Micro Biosystems Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 29.6%.
Rapid Micro Biosystems Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-1.38 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Rapid Micro Biosystems Inc’s profitability.
Rapid Micro Biosystems Inc stock is trading at a EV to sales ratio of 0.1161 and a EV to EBITDA ratio of 0.3654. Its price to sales ratio in the trailing 12-months stood at 3.95.
Rapid Micro Biosystems Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $160.95 million
- Total Liabilities
- $14.42 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $215000
- Dividend Payout Ratio
- 0%
Rapid Micro Biosystems Inc ended 2024 with $160.95 million in total assets and $0 in total liabilities. Its intangible assets were valued at $160.95 million while shareholder equity stood at $139.63 million.
Rapid Micro Biosystems Inc ended 2024 with $0 in deferred long-term liabilities, $14.42 million in other current liabilities, 423000.00 in common stock, $-403821000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $28.68 million and cash and short-term investments were $106.07 million. The company’s total short-term debt was $802,000 while long-term debt stood at $0.
Rapid Micro Biosystems Inc’s total current assets stands at $132.75 million while long-term investments were $0 and short-term investments were $77.39 million. Its net receivables were $3.76 million compared to accounts payable of $1.36 million and inventory worth $20.94 million.
In 2024, Rapid Micro Biosystems Inc's operating cash flow was $0 while its capital expenditure stood at $215000.
Comparatively, Rapid Micro Biosystems Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $1.04
- 52-Week High
- $3.78
- 52-Week Low
- $0.83
- Analyst Target Price
- $5.88
Rapid Micro Biosystems Inc stock is currently trading at $1.04 per share. It touched a 52-week high of $3.78 and a 52-week low of $3.78. Analysts tracking the stock have a 12-month average target price of $5.88.
Its 50-day moving average was $0.97 and 200-day moving average was $1.18 The short ratio stood at 0.72 indicating a short percent outstanding of 0%.
Around 1202.7% of the company’s stock are held by insiders while 7361.6% are held by institutions.
Frequently Asked Questions About Rapid Micro Biosystems Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, onsite technical training, and customer support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. In addition, it offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; and RMBNucleus Central Manager portal streamlines monitoring and reporting. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.